Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40


Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice.

Pacher P, Bátkai S, Kunos G.

J Physiol. 2004 Jul 15;558(Pt 2):647-57. Epub 2004 Apr 30.


In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake.

de Lago E, Ligresti A, Ortar G, Morera E, Cabranes A, Pryce G, Bifulco M, Baker D, Fernandez-Ruiz J, Di Marzo V.

Eur J Pharmacol. 2004 Jan 26;484(2-3):249-57.


Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle.

Bonz A, Laser M, Küllmer S, Kniesch S, Babin-Ebell J, Popp V, Ertl G, Wagner JA.

J Cardiovasc Pharmacol. 2003 Apr;41(4):657-64.


Anandamide-induced depressor effect in spontaneously hypertensive rats: role of the vanilloid receptor.

Li J, Kaminski NE, Wang DH.

Hypertension. 2003 Mar;41(3 Pt 2):757-62. Epub 2002 Dec 30.


Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor.

Offertáler L, Mo FM, Bátkai S, Liu J, Begg M, Razdan RK, Martin BR, Bukoski RD, Kunos G.

Mol Pharmacol. 2003 Mar;63(3):699-705.


Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction.

Pacher P, Liaudet L, Bai P, Mabley JG, Kaminski PM, Virág L, Deb A, Szabó E, Ungvári Z, Wolin MS, Groves JT, Szabó C.

Circulation. 2003 Feb 18;107(6):896-904.


Increased systolic performance with diastolic dysfunction in adult spontaneously hypertensive rats.

Cingolani OH, Yang XP, Cavasin MA, Carretero OA.

Hypertension. 2003 Feb;41(2):249-54.


Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice.

Wang L, Liu J, Harvey-White J, Zimmer A, Kunos G.

Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1393-8. Epub 2003 Jan 21.


Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example.

Wager-Miller J, Westenbroek R, Mackie K.

Chem Phys Lipids. 2002 Dec 31;121(1-2):83-9. Review.


Modulation of anxiety through blockade of anandamide hydrolysis.

Kathuria S, Gaetani S, Fegley D, Valiño F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, Giustino A, Tattoli M, Palmery M, Cuomo V, Piomelli D.

Nat Med. 2003 Jan;9(1):76-81. Epub 2002 Dec 2.


A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.

Gómez R, Navarro M, Ferrer B, Trigo JM, Bilbao A, Del Arco I, Cippitelli A, Nava F, Piomelli D, Rodríguez de Fonseca F.

J Neurosci. 2002 Nov 1;22(21):9612-7.


Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent.

Mukhopadhyay S, Chapnick BM, Howlett AC.

Am J Physiol Heart Circ Physiol. 2002 Jun;282(6):H2046-54.


Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension.

Imig JD, Zhao X, Capdevila JH, Morisseau C, Hammock BD.

Hypertension. 2002 Feb;39(2 Pt 2):690-4.


CB(1) receptor antagonist SR141716A inhibits Ca(2+)-induced relaxation in CB(1) receptor-deficient mice.

Bukoski RD, Bátkai S, Járai Z, Wang Y, Offertaler L, Jackson WF, Kunos G.

Hypertension. 2002 Feb;39(2):251-7.


Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase.

Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, Lichtman AH.

Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9371-6. Epub 2001 Jul 24.


Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors.

Wagner JA, Járai Z, Bátkai S, Kunos G.

Eur J Pharmacol. 2001 Jul 6;423(2-3):203-10.


Supplemental Content

Support Center